OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant
Paul Elliott, David Haw, Haowei Wang, et al.
Science (2021) Vol. 374, Iss. 6574
Open Access | Times Cited: 176

Showing 1-25 of 176 citing articles:

Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
Thibault Fiolet, Yousra Kherabi, Conor-James MacDonald, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 202-221
Open Access | Times Cited: 820

Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
Anika Singanayagam, Seran Hakki, Jake Dunning, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 2, pp. 183-195
Open Access | Times Cited: 753

Rapid increase in Omicron infections in England during December 2021: REACT-1 study
Paul Elliott, Barbara Bodinier, Oliver Eales, et al.
Science (2022) Vol. 375, Iss. 6587, pp. 1406-1411
Open Access | Times Cited: 135

COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant and implications for vaccination
Wan Yang, Jeffrey Shaman
Journal of The Royal Society Interface (2022) Vol. 19, Iss. 191
Open Access | Times Cited: 115

Twin peaks: The Omicron SARS-CoV-2 BA.1 and BA.2 epidemics in England
Paul Elliott, Oliver Eales, Nicholas Steyn, et al.
Science (2022) Vol. 376, Iss. 6600
Open Access | Times Cited: 103

Context-specific emergence and growth of the SARS-CoV-2 Delta variant
John T. McCrone, Verity Hill, Sumali Bajaj, et al.
Nature (2022) Vol. 610, Iss. 7930, pp. 154-160
Open Access | Times Cited: 102

Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions
Manish Dhawan, Abhilasha Sharma, Priyanka Choudhary, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 87

SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys
Marc Chadeau‐Hyam, Haowei Wang, Oliver Eales, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 4, pp. 355-366
Open Access | Times Cited: 68

Vaccine Effectiveness Against Long COVID in Children
Hanieh Razzaghi, Christopher B. Forrest, Kathryn Hirabayashi, et al.
PEDIATRICS (2024) Vol. 153, Iss. 4
Closed Access | Times Cited: 24

Understanding Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination
Michael Klompas
JAMA (2021) Vol. 326, Iss. 20, pp. 2018-2018
Closed Access | Times Cited: 78

Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected With the SARS-CoV-2 Delta Variant
Charlotte B. Acharya, John Schrom, Anthea Mitchell, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 5
Open Access | Times Cited: 62

Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
Laurent Rénia, Yun Shan Goh, Angéline Rouers, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 44

The past, current and future epidemiological dynamic of SARS-CoV-2
François Balloux, Cedric C.S. Tan, Leo Swadling, et al.
Oxford Open Immunology (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 37

Design and Implementation of a National SARS-CoV-2 Monitoring Program in England: REACT-1 Study
Paul Elliott, Matthew Whitaker, David Tang, et al.
American Journal of Public Health (2023) Vol. 113, Iss. 5, pp. 545-554
Open Access | Times Cited: 24

Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England
Oliver Eales, David Haw, Haowei Wang, et al.
PLoS Biology (2023) Vol. 21, Iss. 5, pp. e3002118-e3002118
Open Access | Times Cited: 21

Can a combination of vaccination and face mask wearing contain the COVID‐19 pandemic?
Harald Brüssow, Sophie Zuber
Microbial Biotechnology (2021) Vol. 15, Iss. 3, pp. 721-737
Open Access | Times Cited: 52

Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study
Satveer K. Mahil, Katie Bechman, Antony Raharja, et al.
The Lancet Rheumatology (2021) Vol. 4, Iss. 1, pp. e42-e52
Open Access | Times Cited: 47

COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination
Wan Yang, Jeffrey Shaman
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 45

Dynamics of competing SARS-CoV-2 variants during the Omicron epidemic in England
Oliver Eales, Leonardo de Oliveira Martins, Andrew J. Page, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 36

Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England
Paul Elliott, Oliver Eales, Barbara Bodinier, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 35

Occupations and their impact on the spreading of COVID-19 in urban communities
Marian-Gabriel Hâncean, Jürgen Lerner, Matjaž Perc, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 34

An improved numerical model for epidemic transmission and infection risks assessment in indoor environment
Yidan Shang, Jingliang Dong, Lin Tian, et al.
Journal of Aerosol Science (2022) Vol. 162, pp. 105943-105943
Open Access | Times Cited: 28

Page 1 - Next Page

Scroll to top